Orally taken and externally applied traditional Chinese medicine composite for treating rheumatoid arthritis

Abstract

The invention discloses an orally taken and externally applied traditional Chinese medicine composite for treating rheumatoid arthritis. The composite is prepared from the following first and second groups of medicines in parts by weight: the first group: 20 parts of radix-polygoni multiflori, 10 parts of medlar, 10 parts of eucommia bark, 10 parts of Curculigo orchioides, 10 parts of epimedium, 20 parts of Fructus Psoraleae, 10 parts of ginseng, 10 parts of ophiopogon root, 15 parts of angelica, 20 parts of radix sileris, 12 parts of prepared radix aconiti carmichaeli, 15 parts of radix aconiti preparata, 10 parts of tuckahoe, 15 parts of pawpaw, 10 parts of radix angelicae pubescentis, 10 parts of Salvia miltiorrhiza, 15 parts of Scutellaria baicalensis, 10 parts of radix curcumae, 20 parts of rehmannia and 6 parts of liquorice; the second group: 20 parts of radix angelicae, 10 parts of monkshood, 10 parts of radix aconiti agrestis, 15 parts of radix sileris, 20 parts of rhizoma atractylodis, 10 parts of rhizoma arisaematis, 10 parts of peach kernel, 10 parts of angelica, 5 parts of natural borneol, 10 parts of sinapis semina and 3 parts of asarum, wherein the first group of medicines is orally taken medicines, and the second group of medicines is externally applied medicines. The total effective rate is 95.0 percent, according to 60 cases of the composite used to treat patients with rheumatoid arthritis.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating rheumatoid arthritis, belonging to the field of traditional Chinese medicines. Background technique [0002] Rheumatoid arthritis is a personal disease mainly characterized by non-suppurative inflammation of joints and periarticular tissues, often accompanied by extra-articular symptoms, so it is called rheumatoid. Synovial inflammation in the joint cavity, exudate, cell proliferation, granuloma formation, cartilage and bone tissue destruction, and finally joint ankylosis and dysfunction. It often invades small joints, such as hands, feet, and wrist joints. It is often symmetrical and has a chronic course. There may be temporary relief. Due to multi-system damage, autoantibodies can be found in the serum, so the disease is considered to be an autologous disease. . The age of onset is mostly between 20 and 40 years old. Women outnumber men. How to use drugs rationally, ...

AI Technical Summary

Problems solved by technology

At present, there are traditional Chinese medicines with good curative effect in the treatment of rheumatoid arthritis, such as triptolide or tripterygium polyglycoside tablets, etc. Clinical reports have achieved good curative effect, but the toxic and side effects of this drug have affected its application prospect

[0005] The following problems exist in the domestic diagnosis and treatment: (1) Inaccurate diagnosis: there is no diagnosis according to the classification standard of rheumatoid arthritis, which has a high rate of misdiagnosis and missed diagnosis

(2) The purpose of treatment is not clear: many doctors and patients regard pain relief as the only purpose

(3) Improper application of non-steroidal anti-inflammatory drugs: the main problem is the small dosage and frequent drug changes

(4) Improper application of glucocorticoids: the main problem is excessive dosage and long-term use

(5) Improper application of slow-acting drugs: the main problem is that the application is too late, too little and the course of treatment is too short